Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer
about
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?Small-molecule SMAC mimetics as new cancer therapeuticsPutting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy?The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancerA rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancerComparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancerTargeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134.BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitroTherapeutic options for the management of pancreatic cancer.SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent mannerApricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cellsGenomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivoSmac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer.Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cellsFas death receptor signalling: roles of Bid and XIAP.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Cell death signaling and anticancer therapyMechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of ApoptosisStromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer.Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignancies.Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin.Anti-cancer IAP antagonists promote bone metastasis: a cautionary tale.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.Proteomic tools for the characterization of cell death mechanisms in drug discovery.Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor.Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitro.Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing.
P2860
Q26771601-ADFB25E0-B2DD-4D0F-93E3-8D5F172978B8Q26864204-CF0850D8-50D4-4513-8C1B-0BD92F404B52Q28085240-75AEC07E-1D7C-4ED0-9EF9-5A349D260123Q28468300-CD9F185C-58F7-41AD-A522-787D08012829Q30669159-9804F04D-1021-4421-BCF4-B2F2D4CD74F0Q33589984-C60DC519-A5A6-4CDD-A9AE-BEB4DBA9FFFDQ33621256-A20261EA-7F18-4ABF-9824-1C9C421DD288Q33849311-FFB072E8-0F9B-4E54-9987-63459227686AQ33961325-8CAE5069-019E-4D28-B87B-0993F47A5BA4Q34093776-4EFC29C8-605C-44F0-9AED-9F647FA4E271Q34229779-64E38C3B-D8BA-40AE-9A13-2B240059D8E4Q34290118-20F2D382-AEA2-42D8-A427-FBB99E2504D6Q34512395-34033B4D-CE3B-4543-8EA3-375413BF2EF5Q34541180-6F7D17C4-9446-418B-B460-E507FA10F9C1Q34556212-A30DFFB5-1DBC-4535-9466-E8F1D3E733A7Q35097256-B7C10BCD-2A2B-4D14-96F9-D8264A1D1B74Q35338435-427EAD36-DE6A-4CC1-9E8B-F7DF428892DAQ35657414-A53D535F-0BCE-42B3-8D7B-0138327F2DC2Q35870682-97DCB2D5-543C-417D-8EA8-5C316048A505Q35972102-5A847D16-5FA6-4BDB-ABFB-542A11AD81ADQ36094941-20AC4DBD-F68E-4A53-A1D2-39021F3C4B56Q36342854-BE90DF83-7BEB-42DE-B161-70CC0C036862Q36373429-F7500F63-419D-49F5-8D18-BD5F2495DD31Q36392642-5EC24E7D-6A96-41AE-AB1B-7EB9827A2405Q36413644-A621273E-F289-454F-8DF8-D76F589F02CCQ36851289-BC600A59-816A-4449-9DA6-6EF750F018CFQ36927086-0478053F-6CDE-4DE0-85CC-5862A02BBF7BQ37123892-2812C1DA-EF78-4F65-8F12-968AD1539D03Q37357090-8E6CF6A8-027B-43DA-A703-11C63576AE88Q37540196-769F881D-BA10-4FB0-B2AD-6DF15155810FQ37654710-3BE8FFEA-57CB-4742-A9BF-3A75A8F64823Q37867584-E6F648F4-88B2-4C39-B39C-9F024D80275FQ37875078-50416914-F4BC-4722-9213-C9A5B7D91493Q38364625-D5626F62-B9F1-4D38-B74D-9C5099A3057EQ38712272-8791AD50-3644-43B9-B811-789DCA48BAEFQ38713584-08072568-CC6D-44FF-B519-E6F08DB6D640Q38927472-A7B878A7-6288-4A81-B259-6612D9425030Q38971921-06F009CF-79DA-4601-8D8B-0C278C8086CCQ39042485-D52A3E16-8A71-4F69-9085-101AB301E501Q39148654-3FA87D19-0322-4406-8E57-B120F4F369DE
P2860
Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Smac mimetic increases chemoth ...... in mice with pancreatic cancer
@ast
Smac mimetic increases chemoth ...... in mice with pancreatic cancer
@en
type
label
Smac mimetic increases chemoth ...... in mice with pancreatic cancer
@ast
Smac mimetic increases chemoth ...... in mice with pancreatic cancer
@en
prefLabel
Smac mimetic increases chemoth ...... in mice with pancreatic cancer
@ast
Smac mimetic increases chemoth ...... in mice with pancreatic cancer
@en
P2093
P2860
P1433
P1476
Smac mimetic increases chemoth ...... in mice with pancreatic cancer
@en
P2093
Christina L Roland
Haizhou Sun
Jason E Toombs
John D Minna
Juliet G Carbon
Nabeel Bardeesy
Noelle Williams
Puja Gupta
Rachel Greer
Rolf A Brekken
P2860
P304
P356
10.1158/0008-5472.CAN-09-3892
P407
P577
2010-03-23T00:00:00Z